Search research articles
Contact Us
Filters
Showing results (311-320 of 490) with videos related to
Page
of 49
Sort By:
Oncoimmunology
|
June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
International Journal of Cancer
|
April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
Qian Sun, Daniel Novak, Laura Hüser, et al.
Cell Death & Disease
|
October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12
Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Cell Stem Cell
|
March 29, 2008
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Nimet Maherali, Rupa Sridharan, Wei Xie, et al.
Stem Cell Reports
|
April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
Eleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Cancers
|
February 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
February 6, 2022
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status
Viola K DeTemple, Cathrin Ritter, Nalini Srinivas, et al.
Page
of 49
Search research articles
Search
Showing results (311-320 of 490) with videos related to
Sort By:
Page
of 49
Oncoimmunology
|
June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
International Journal of Cancer
|
April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
Qian Sun, Daniel Novak, Laura Hüser, et al.
Cell Death & Disease
|
October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12
Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Cell Stem Cell
|
March 29, 2008
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Nimet Maherali, Rupa Sridharan, Wei Xie, et al.
Stem Cell Reports
|
April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
Eleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Cancers
|
February 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
February 6, 2022
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status
Viola K DeTemple, Cathrin Ritter, Nalini Srinivas, et al.
Page
of 49